Macrogenics (MGNX) Misses Q1 EPS by 20c

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.84), $0.20 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $14.86 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Royal Unibrew reports higher interim first-half profit as margins improve
• MacroGenics (MGNX) PT Raised to $11 at B.Riley